Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × NIH × Anidulafungin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neutropenia 1 Infections 1

Interventions

Cyclophosphamide 43 Biopsy 33 Specimen Handling 30 Magnetic Resonance Spectroscopy 28 fludarabine 27 aldesleukin 25 Filgrastim 19 Carboplatin 19 Paclitaxel 18 fludarabine phosphate 16 Rituximab 15 Cisplatin 15 Etoposide 14 Temozolomide 13 Radiotherapy 13 Prednisone 13 Docetaxel 13 Cytarabine 13 Bevacizumab 13 Sirolimus 12 Erlotinib Hydrochloride 12 Gemcitabine 11 Vincristine 10 Fluorouracil 10 Doxorubicin 10 Vorinostat 9 sargramostim 8 Topotecan 8 Taxes 8 Sorafenib 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00068471 2013-06-19

Anidulafungin in Treating Immunocompromised Children With Neutropenia

National Cancer Institute (NCI)

Phase 1/2 Completed

Infections, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡